Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas
- PMID: 8187085
Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas
Abstract
Tumor specific rearrangements of ret gene are frequently detected in papillary thyroid carcinomas. These rearrangements result in the formation of chimeric genes showing the tyrosine kinase domain of ret fused with the 5' end sequences of different genes. We examined a series of 52 patients and identified 10 cases of ret fusion with D10S170 locus resulting in the generation of ret/PTC1 oncogene, 2 cases with the gene encoding the regulatory subunit RI alpha of PKA (ret/PTC2), and finally 6 cases, here described, with a newly discovered gene called ele1 localized on chromosome 10 and leading to the formation of ret/PTC3 oncogene. Our results show the expression of the ret/PTC3 hybrid gene in all the 6 cases and demonstrated its association with the synthesis of 2 constitutively phosphorylated isoforms of the oncoprotein (p75 and p80). The chromosome 10 localization of both ret and ele1 and the detection, in all cases, of a sequence reciprocal to that generating the oncogenic rearrangements, strongly suggest that ret/PTC3 formation is a consequence of an intrachromosomal inversion of chromosome 10.
Similar articles
-
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.Oncogene. 1994 Feb;9(2):509-16. Oncogene. 1994. PMID: 8290261
-
RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes.Genomics. 2001 Apr 15;73(2):149-60. doi: 10.1006/geno.2000.6434. Genomics. 2001. PMID: 11318605
-
Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer.Oncogene. 1996 Sep 5;13(5):1093-7. Oncogene. 1996. PMID: 8806699
-
Molecular genetics of childhood papillary thyroid carcinomas after irradiation: high prevalence of RET rearrangement.Recent Results Cancer Res. 1998;154:248-64. doi: 10.1007/978-3-642-46870-4_16. Recent Results Cancer Res. 1998. PMID: 10027005 Review.
-
The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clinical implications.Virchows Arch. 1997 Jul;431(1):1-9. doi: 10.1007/s004280050062. Virchows Arch. 1997. PMID: 9247627 Review.
Cited by
-
Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis.BJS Open. 2023 May 5;7(3):zrad029. doi: 10.1093/bjsopen/zrad029. BJS Open. 2023. PMID: 37146205 Free PMC article.
-
RET signaling pathway and RET inhibitors in human cancer.Front Oncol. 2022 Jul 25;12:932353. doi: 10.3389/fonc.2022.932353. eCollection 2022. Front Oncol. 2022. PMID: 35957881 Free PMC article. Review.
-
Genomic variation as a marker of response to neoadjuvant therapy in locally advanced rectal cancer.Mol Cell Oncol. 2020 Mar 2;7(3):1716618. doi: 10.1080/23723556.2020.1716618. eCollection 2020. Mol Cell Oncol. 2020. PMID: 32391418 Free PMC article.
-
RET Gene Fusions in Malignancies of the Thyroid and Other Tissues.Genes (Basel). 2020 Apr 15;11(4):424. doi: 10.3390/genes11040424. Genes (Basel). 2020. PMID: 32326537 Free PMC article. Review.
-
Investigation of the clonal origin of multifocal papillary thyroid carcinoma according to the X-chromosome inactivation pattern.Oncol Lett. 2019 May;17(5):4695-4700. doi: 10.3892/ol.2019.10105. Epub 2019 Mar 4. Oncol Lett. 2019. PMID: 30944656 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials